LYON, France--(BUSINESS WIRE)--Oct 22, 2008 - ERYtech Pharma, a French biotechnology company, will present very promising results from its original approach on antitumor vaccination at the 6th ...

Lyon (France) and Cambridge, MA (U.S.), February 8, 2021– ERYTECH Pharma (Nasdaq & Euronext: ERYP),a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating ...

As of late, it has definitely been a great time to be an investor ERYTECH Pharma S.A. ERYP. The stock has moved higher by 0.6% in the past month, while it is also above its 20 Day SMA too. This ...

In February, Erytech Pharma SA ERYP announced its proposed combination with Pherecydes Pharma S.A. In June, Erytech announced that Akkadian initiated proceedings to postpone the vote, scheduled on 23 ...

(RTTNews) - ERYTECH Pharma S.A. (ERYP), a clinical-stage biopharmaceutical company developing red blood-cell based cancer therapeutics, has been granted Fast Track designation for its lead drug ...

All resolutions voted with a large majority according to Board of Directors recommendations Company renamed Phaxiam Therapeutics, creating a world leader in phage therapy Lyon (France), June 23, 2023 ...

Days after throwing down $350 million to beef up biologics manufacturing in Indiana, high-flying CDMO Catalent is buying a cell therapy plant on the East Coast. Catalent has paid $44.5 million for ...

NANTES, France--(BUSINESS WIRE)--Regulatory News: PHERECYDES Pharma (FR0011651694 – ALPHE), a biotechnology company specializing in extended phage therapy for treating antibiotic-resistant and/or ...

The first clinical trial using Graspa® on a solid tumor. A good safety profile for Graspa® in last-line therapy patients. A major step forward in its flagship product deployment in solid tumors.

Thank you for standing by, and welcome to the conference call on the proposed merger between ERYTECH Pharma and Pherecydes Pharma. [Operator Instructions]. As a reminder, today's program is being ...